Salus Science Corporation Notice regarding the research that our company’s CEO, Keisuke Taniuchi, is conducting at Kochi University. | サルスサイエンス株式会社

NEWS

Notice regarding the research that our company’s CEO, Keisuke Taniuchi, is conducting at Kochi University.

Associate Professor Keisuke Taniuchi (Department of Gastroenterology, Kochi University School of Medicine) is participating in a project to develop nucleic acid drugs for pancreatic cancer. The Japan Agency for Medical Research and Development (AMED) has adopted this project as a “Basic Technology Development Project for Next Generation Drug Discovery and Diagnosis.” For more information, please refer to the Kochi University website on below.

https://www.kochi-u.ac.jp/information/2025063000017

Back To List